Issue IndexA searchable index of tables of contents
Find An Issue
Table of contents for
July 31, 2003 Vol. 349 No. 5
- Free Full Text
In this study, bacterial meningitis was identified in 26 children with cochlear implants, at an incidence far higher than that among other children. The risk was greatest with implants that included a Silastic wedge, which the manufacturers recalled in July 2002. The risk was also increased among children with inner-ear malformations or cerebrospinal fluid leaks.
- Free Full Text
Elevated calcium and phosphorus levels associated with secondary hyperparathyroidism may accelerate vascular disease in patients undergoing long-term hemodialysis. This prospective but nonrandomized historical cohort study compared calcitriol, the standard injectable therapy, with paricalcitol, a new vitamin D analogue that causes less elevation of calcium. Paricalcitol was associated with a lower mortality rate than calcitriol (0.180 vs. 0.223 death per person-year).
- Free Full Text
Bisphosphonates are increasingly used in conditions such as osteogenesis imperfecta and juvenile osteoporosis. Their potential adverse effects in growing children have been a concern, however, since bisphosphonates inhibit skeletal resorption by suppressing the activity and function of osteoclasts. The authors describe a case of drug-induced osteopetrosis in a 12-year-old boy who had received high doses of pamidronate for nearly three years.
- Free Full Text
A healthy 40-year-old man exercises regularly, uses no tobacco, and has no cardiac symptoms. His blood pressure is 120/80 mm Hg, his total cholesterol concentration is 180 mg per deciliter, his high-density lipoprotein cholesterol concentration is 50 mg per deciliter, his body-mass index is 24, his fasting blood glucose concentration is 95 mg per deciliter, and he has no family history of coronary disease. Should he be advised to undergo coronary computed tomography or electrocardiographic exercise testing so that the assessment of his coronary risk may be refined?
Drug-induced hepatic injury accounts for more than 50 percent of cases of acute liver failure in the United States. More than 75 percent of idiosyncratic drug reactions result in liver transplantation or death. This review discusses the pathogenesis of drug-induced liver injury, common adverse drug reactions involving the liver, and the drug-approval process. Monitoring for and recognition of drug-induced hepatotoxicity may prevent some cases of acute hepatic failure.
- Free Full Text
- Free Full Text
- Free Full Text
- Free Full Text
- Free Full Text






